Aramune Technologies raises £800k to scale and trial its first product

  • Aramune Technologies has raised £800,000 of new equity funding to develop an industrial-scale process for manufacturing its first product.

    The Queen’s University Belfast spinout is developing natural, plant derived feed materials which can be mixed with standard animal feeds to replace antimicrobial agents and promote growth.

    Their venture is supported by a syndicate of investors which includes QUBIS which is the commercialisation arm of Queen’s University, Co-Fund NI (managed by Clarendon Fund Managers), the QUBIS Innovation Fund (managed by Sapphire Capital Partners) and a local private investor.

    RELATED: Design teams announced for ambitious Queen’s-led City Deal Innovation Centres

    Commenting on the completion of the seed round Ashley Cooper, CEO, said: “We are delighted to have secured this funding from local investors who are committed to supporting Queen’s spin-out ventures and the local economy. With this funding we are now well placed to rapidly exploit the very many commercial applications of our proprietary Aramune compound.”

    QUBIS Corporate Finance Manager Oisin Lappin said: “Aramune is an exciting new spinout venture that has emerged from the Queen’s Institute of Global Food Security and we are delighted to support the team as they begin their commercialisation journey.”

    The Belfast company is developing multiple applications for their patented plant compounds that can benefit animal and human health. The unique approach boosts the immune system, increasing natural resistance to bacterial infection, which in turn should minimise the occurrence of antimicrobial resistance (AMR) in animals and humans.

    RELATED: Ten Early-Stage Ventures Commence NovaUCD’s 2022 Start-up Programme for Student Entrepreneurs

    The proceeds will enable the business to field cultivate their source plants, industrially scale their compound extraction procedures and undertake more commercial trials.

    Brian Green, Chief Scientific Officer of Aramune Technologies, said: “This investment is a vote of confidence in the commercial potential of our research, and it follows on from Aramune’s recent successes. In 2021 we won £300,000 of funding from Innovate UK and were Regional winners of the InterTradeIreland Seedcorn investor readiness competition.”

    For further information please visit: www.aramune.com  or contact info@aramune.com

    Source: Written from press release.

    About the author

    Aoife is a Sync NI writer with a previous background working in print, online and broadcast media. She has a keen interest in all things tech related. To connect with Aoife feel free to send her an email or connect on LinkedIn.

    Got a news-related tip you’d like to see covered on Sync NI? Email the editorial team for our consideration.

    Sign up now for a FREE weekly newsletter showcasing the latest news, jobs and events in NI’s tech sector.

Share this story